• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 1055

Xylanase enzyme preparation produced by Bacillus licheniformis strain expressing the xylanase gene from Chryseobacterium

Intended Use: Intended for use as an enzyme at up to 68.5 mg Total Organic Solids (TOS)/kg raw material in grain processing, brewing, and manufacture of cereal-based beverages.
Basis: Scientific procedures
Notifier: Novozymes North America Inc.
Notifier Address: 77 Perrys Chapel Church Road
Franklinton, NC 27525
GRAS Notice (releasable information): GRN 1055 with Amendments (in PDF) (3.0 MB)
Date of closure: Apr 4, 2023
FDA's Letter: FDA Has No Questions (in PDF) (265 kB)